{
    "nctId": "NCT03250130",
    "briefTitle": "Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL)",
    "officialTitle": "Medical Ericksonian Hypnosis on Patients Treated With Adjuvant Chemotherapy for Breast Cancer at the ICM Val d'Aurelle - Montpellier: a Feasibility Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 35,
    "primaryOutcomeMeasure": "proportion of patients rated as being compliant to self-hypnosis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* \u2022 Female, age \\> 18 years-old\n\n  * Without previous practice of hypnosis\n  * Patient with diagnosis of breast cancer\n  * Patient receiving an adjuvant chemotherapy for at least 3 months with an indication of radiotherapy after chemotherapy\n  * Patient accepting the principle of the study with a signed written informed consent\n  * Patient affiliated to French Social Security\n\nExclusion Criteria:\n\n* \u2022 Male\n\n  * Age \\< 18 years\n  * Patient refusing hypnosis\n  * Pregnancy, breast-feeding, or lack of effective contraception in female patients with reproductive potential.\n  * Patient with psychological or mental disorders under psychotropic treatments (lithium, neuroleptics)\n  * Not ability to speak and read French, deaf and/or mute",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}